BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
NASA's Artemis 2 pilot Victor Glover listens to 'Whitey on the Moon' every Monday. This is why. - 2Courageous Climbing: Trails and Stuff for Outside Lovers
- 3European nations criticise Israel’s death penalty plans
- 4This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- 5Building an Individual Brand: Illustrations from Forces to be reckoned with
- Figure out how to Detect the Best Rooftop Substitution Choices
- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- The Best 15 Applications for Efficiency and Association
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- Monetary Strengthening: Assuming Command over Your Cash
- Whale stranded off Germany for days free again
- Getting breast implants was a mistake I live with every day. Why I’m sharing my story now, at 70, in pain and afraid.
- From White Elephant to Favorite Things parties, here are all the rules you need to know every kind of gift exchange
- New ‘Cloud-9’ object could reveal the secrets of dark matter
